Genopole

investment firm

About

Genopole is France's leading biotech and biotherapy-dedicated science and business park.

Details

Industries
Genetics
Founded date
Jan 1, 1998
Operating Status
Active
Investor Type
Government Office,Venture Capital

Genopole® is France’s leading biotech- and biotherapy-dedicated science and business park

The Genopole® project was initiated in 1998 in the town of Evry-Corbeil (in the Essonne county, just south of Paris), under the impetus of the French government, Ile-de-France Regional Council, Essonne County Council and the French Muscular Dystrophy Association (Association Française contre les Myopathies, AFM); the goal was to create France’s first ever science and business park dedicated to genomics, genetics and biotech and help the country to catch up with its international rivals in these fields.

By modeling itself on world-class North American and European bioclusters, Genopole® has pioneered this approach in France.

In addition to constant support from its founding members and other partners, Genopole®’s success is largely based on the novelty of its approach: bringing together public- and private-sector research labs, university teaching facilities and life science start-ups on a single campus in Evry–Corbeil.

Investments

Number of Investments
Number of Lead Investments
1
0
Genopole has made 1 investments. Their most recent investment was on Jun 16, 2008, when CellVir raised $387K.
Date Company Name
Round Money Raised Industry Lead Investor
Jun 16, 2008 CellVir
Series Unknown $387K Biotechnology

Employee Profiles

Number of Employee Profiles
5
Genopole has 5 current employee profiles, including Executive David Bodet